Provided by Tiger Trade Technology Pte. Ltd.

Roundhill GLP-1 & Weight Loss ETF

33.32
-0.2676-0.80%
Volume:9K
Turnover:300.60K
Market Cap:64.31M
PE:- -
High:33.52
Open:33.52
Low:33.22
Close:33.59
52wk High:37.15
52wk Low:25.66
Shares:1.93M
Float Shares:1.93M
Volume Ratio:2.49
T/O Rate:0.47%
Dividend:0.41
Dividend Rate:1.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Aug 24

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Aug 24

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Aug 24

Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

TIPRANKS
·
Aug 22

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case (PFE)?

Simply Wall St.
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Pfizer’s India Migraine Study Adds Real-World Momentum for PFE

TIPRANKS
·
Aug 22

Pfizer’s Real World Prostate Cancer Study Sets Up a New Test for Leading Therapies

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

TIPRANKS
·
Aug 22

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

TIPRANKS
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

NYSE Most Active Issues

Dow Jones
·
Aug 21

Cboe data shows mixed options sentiment in Pfizer with shares down 1.5%

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20